STUDY TO INVESTIGATE THE PHARMACOKINETIC INTERACTION BETWEEN 2 DIRECT ACTING ANTIVIRAL AGENTS ODALASVIR AND AL-335 AND BETWEEN 3 DIRECT ACTING ANTIVIRAL AGENTS SIMEPREVIR, ODALASVIR AND AL-335 AT STEADY STATE IN HEALTHY JAPANESE PARTICIPANTS: